[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Procalcitonin-Europe Market Status and Trend Report 2013-2023

December 2017 | 149 pages | ID: P5387013EABEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Procalcitonin-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Procalcitonin industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole Europe and Regional Market Size of Procalcitonin 2013-2017, and development forecast 2018-2023
Main market players of Procalcitonin in Europe, with company and product introduction, position in the Procalcitonin market
Market status and development trend of Procalcitonin by types and applications
Cost and profit status of Procalcitonin, and marketing status
Market growth drivers and challenges

The report segments the Europe Procalcitonin market as:

Europe Procalcitonin Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

Germany
United Kingdom
France
Italy
Spain
Benelux
Russia

Europe Procalcitonin Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Procalcitonin Antigen
Procalcitonin Antibody

Europe Procalcitonin Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medical Industry
Scientific Research

Europe Procalcitonin Market: Players Segment Analysis (Company and Product introduction, Procalcitonin Sales Volume, Revenue, Price and Gross Margin):

Thermo Fisher
Roche Diagnostics
BioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine’nest Pharmaceutical
Kitgen
Beijing KeyGen
Beijing Apis

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF PROCALCITONIN

1.1 Definition of Procalcitonin in This Report
1.2 Commercial Types of Procalcitonin
  1.2.1 Procalcitonin Antigen
  1.2.2 Procalcitonin Antibody
1.3 Downstream Application of Procalcitonin
  1.3.1 Medical Industry
  1.3.2 Scientific Research
1.4 Development History of Procalcitonin
1.5 Market Status and Trend of Procalcitonin 2013-2023
  1.5.1 Europe Procalcitonin Market Status and Trend 2013-2023
  1.5.2 Regional Procalcitonin Market Status and Trend 2013-2023

CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Procalcitonin in Europe 2013-2017
2.2 Consumption Market of Procalcitonin in Europe by Regions
  2.2.1 Consumption Volume of Procalcitonin in Europe by Regions
  2.2.2 Revenue of Procalcitonin in Europe by Regions
2.3 Market Analysis of Procalcitonin in Europe by Regions
  2.3.1 Market Analysis of Procalcitonin in Germany 2013-2017
  2.3.2 Market Analysis of Procalcitonin in United Kingdom 2013-2017
  2.3.3 Market Analysis of Procalcitonin in France 2013-2017
  2.3.4 Market Analysis of Procalcitonin in Italy 2013-2017
  2.3.5 Market Analysis of Procalcitonin in Spain 2013-2017
  2.3.6 Market Analysis of Procalcitonin in Benelux 2013-2017
  2.3.7 Market Analysis of Procalcitonin in Russia 2013-2017
2.4 Market Development Forecast of Procalcitonin in Europe 2018-2023
  2.4.1 Market Development Forecast of Procalcitonin in Europe 2018-2023
  2.4.2 Market Development Forecast of Procalcitonin by Regions 2018-2023

CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES

3.1 Whole Europe Market Status by Types
  3.1.1 Consumption Volume of Procalcitonin in Europe by Types
  3.1.2 Revenue of Procalcitonin in Europe by Types
3.2 Europe Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Germany
  3.2.2 Market Status by Types in United Kingdom
  3.2.3 Market Status by Types in France
  3.2.4 Market Status by Types in Italy
  3.2.5 Market Status by Types in Spain
  3.2.6 Market Status by Types in Benelux
  3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Procalcitonin in Europe by Types

CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Procalcitonin in Europe by Downstream Industry
4.2 Demand Volume of Procalcitonin by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Procalcitonin by Downstream Industry in Germany
  4.2.2 Demand Volume of Procalcitonin by Downstream Industry in United Kingdom
  4.2.3 Demand Volume of Procalcitonin by Downstream Industry in France
  4.2.4 Demand Volume of Procalcitonin by Downstream Industry in Italy
  4.2.5 Demand Volume of Procalcitonin by Downstream Industry in Spain
  4.2.6 Demand Volume of Procalcitonin by Downstream Industry in Benelux
  4.2.7 Demand Volume of Procalcitonin by Downstream Industry in Russia
4.3 Market Forecast of Procalcitonin in Europe by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PROCALCITONIN

5.1 Europe Economy Situation and Trend Overview
5.2 Procalcitonin Downstream Industry Situation and Trend Overview

CHAPTER 6 PROCALCITONIN MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE

6.1 Sales Volume of Procalcitonin in Europe by Major Players
6.2 Revenue of Procalcitonin in Europe by Major Players
6.3 Basic Information of Procalcitonin by Major Players
  6.3.1 Headquarters Location and Established Time of Procalcitonin Major Players
  6.3.2 Employees and Revenue Level of Procalcitonin Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 PROCALCITONIN MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Thermo Fisher
  7.1.1 Company profile
  7.1.2 Representative Procalcitonin Product
  7.1.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Thermo Fisher
7.2 Roche Diagnostics
  7.2.1 Company profile
  7.2.2 Representative Procalcitonin Product
  7.2.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.3 BioMerieux
  7.3.1 Company profile
  7.3.2 Representative Procalcitonin Product
  7.3.3 Procalcitonin Sales, Revenue, Price and Gross Margin of BioMerieux
7.4 HyTest
  7.4.1 Company profile
  7.4.2 Representative Procalcitonin Product
  7.4.3 Procalcitonin Sales, Revenue, Price and Gross Margin of HyTest
7.5 BBI Solutions
  7.5.1 Company profile
  7.5.2 Representative Procalcitonin Product
  7.5.3 Procalcitonin Sales, Revenue, Price and Gross Margin of BBI Solutions
7.6 ProSpec
  7.6.1 Company profile
  7.6.2 Representative Procalcitonin Product
  7.6.3 Procalcitonin Sales, Revenue, Price and Gross Margin of ProSpec
7.7 Wondfo
  7.7.1 Company profile
  7.7.2 Representative Procalcitonin Product
  7.7.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Wondfo
7.8 Ningbo Medicalsystem Biotechnology
  7.8.1 Company profile
  7.8.2 Representative Procalcitonin Product
  7.8.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Ningbo Medicalsystem Biotechnology
7.9 Wuhan Easy Diagnosis Biomedicine
  7.9.1 Company profile
  7.9.2 Representative Procalcitonin Product
  7.9.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Wuhan Easy Diagnosis Biomedicine
7.10 Snibe
  7.10.1 Company profile
  7.10.2 Representative Procalcitonin Product
  7.10.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Snibe
7.11 Vazyme Biotech
  7.11.1 Company profile
  7.11.2 Representative Procalcitonin Product
  7.11.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Vazyme Biotech
7.12 Getein Biotech
  7.12.1 Company profile
  7.12.2 Representative Procalcitonin Product
  7.12.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Getein Biotech
7.13 Hotgen Biotech
  7.13.1 Company profile
  7.13.2 Representative Procalcitonin Product
  7.13.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Hotgen Biotech
7.14 Lumigenex
  7.14.1 Company profile
  7.14.2 Representative Procalcitonin Product
  7.14.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Lumigenex
7.15 Shanghai Medicine’nest Pharmaceutical
  7.15.1 Company profile
  7.15.2 Representative Procalcitonin Product
  7.15.3 Procalcitonin Sales, Revenue, Price and Gross Margin of Shanghai Medicine’nest Pharmaceutical
7.16 Kitgen
7.17 Beijing KeyGen
7.18 Beijing Apis

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PROCALCITONIN

8.1 Industry Chain of Procalcitonin
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PROCALCITONIN

9.1 Cost Structure Analysis of Procalcitonin
9.2 Raw Materials Cost Analysis of Procalcitonin
9.3 Labor Cost Analysis of Procalcitonin
9.4 Manufacturing Expenses Analysis of Procalcitonin

CHAPTER 10 MARKETING STATUS ANALYSIS OF PROCALCITONIN

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications